Stockreport

ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

ProMIS Neurosciences Inc.  (PMN) 
PDF CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focuse [Read more]